Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin <scp>II</scp> type 2 receptor agonist

Erik Rein‐Hedin, Folke Sjöberg, Cecilia Ganslandt, Johan Skoog, Helene Zachrisson, Thomas Bengtsson, Carl‐Johan Dalsgaard

Open source

DOI
10.1111/cts.13735
Published
2024-02
Container
Clinical and Translational Science
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cts.13735,
  title = {Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin <scp>II</scp> type 2 receptor agonist},
  author = {Erik Rein‐Hedin and Folke Sjöberg and Cecilia Ganslandt and Johan Skoog and Helene Zachrisson and Thomas Bengtsson and Carl‐Johan Dalsgaard},
  year = {2024},
  journal = {Clinical and Translational Science},
  doi = {10.1111/cts.13735},
  url = {https://doi.org/10.1111/cts.13735}
}

RIS

TY  - JOUR
TI  - Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin <scp>II</scp> type 2 receptor agonist
AU  - Erik Rein‐Hedin
AU  - Folke Sjöberg
AU  - Cecilia Ganslandt
AU  - Johan Skoog
AU  - Helene Zachrisson
AU  - Thomas Bengtsson
AU  - Carl‐Johan Dalsgaard
PY  - 2024
JO  - Clinical and Translational Science
DO  - 10.1111/cts.13735
UR  - https://doi.org/10.1111/cts.13735
ER  - 

APA

Rein‐Hedin, E., Sjöberg, F., Ganslandt, C., Skoog, J., Zachrisson, H., Bengtsson, T., & Dalsgaard, C. (2024). Utilizing venous occlusion plethysmography to assess vascular effects: A study with buloxibutid, an angiotensin <scp>II</scp> type 2 receptor agonist. Clinical and Translational Science. https://doi.org/10.1111/cts.13735

Source records